S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
NFLX   386.19 (-0.41%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
NFLX   386.19 (-0.41%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
NFLX   386.19 (-0.41%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
NFLX   386.19 (-0.41%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

Karyopharm Therapeutics SEC Filings & 10K Form (NASDAQ:KPTI)

$16.32
-0.02 (-0.12 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
$16.12
Now: $16.32
$17.48
50-Day Range
$15.38
MA: $17.29
$19.22
52-Week Range
$3.92
Now: $16.32
$20.09
Volume50,171 shs
Average Volume966,303 shs
Market Capitalization$1.02 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.49

SEC Filings

Karyopharm Therapeutics (NASDAQ:KPTI) SEC Filings

DateFilerForm TypeView
02/14/2020
2:31 PM
Chione Ltd (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/14/2020
2:07 PM
Karyopharm Therapeutics (Subject)
Palo Alto Investors LP (Filed by)
Form SC 13G/A
02/14/2020
12:34 PM
Consonance Capital Management LP (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/14/2020
9:23 AM
Avoro Capital Advisors LLC (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G
02/13/2020
12:43 PM
Karyopharm Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/13/2020
6:09 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2020
3:21 PM
Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
3:20 PM
Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2020
4:07 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
01/13/2020
4:02 PM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
6:12 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
4:07 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
4:04 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2019
8:15 AM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2019
8:06 AM
Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
3:04 PM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
4:26 PM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
4:24 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
4:21 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2019
4:18 PM
Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
6:30 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
4:22 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G
11/12/2019
3:39 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:34 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
8:03 AM
Karyopharm Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/05/2019
3:44 PM
Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/05/2019
3:10 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:08 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
6:23 AM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
6:07 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
3:56 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
3:54 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
6:09 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
4:06 PM
Karyopharm Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2019
3:15 PM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:06 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
6:13 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
4:00 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G
07/15/2019
3:05 PM
Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
6:08 PM
Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2019
12:10 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:05 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
6:33 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
3:05 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
7:59 AM
Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
7:58 AM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
7:57 AM
Greene Barry E (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
7:55 AM
Garland J. Scott (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
7:54 AM
Dolsten Mikael (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
7:53 AM
BOHLIN GAREN G (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
3:10 PM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
6:10 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
11:15 PM
Karyopharm Therapeutics (Filer)
Form EFFECT
04/19/2019
3:08 PM
Karyopharm Therapeutics (Filer)
Form DEFA14A
04/19/2019
3:05 PM
Karyopharm Therapeutics (Filer)
Form DEF 14A
03/15/2019
6:00 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
7:28 PM
Chione Ltd (Reporting)
Czernik Marcin (Reporting)
Hadjimichael Andreas (Reporting)
Hadjimichael George (Reporting)
Karyopharm Therapeutics (Issuer)
Smolokowski Wiaczeslaw (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
4:03 PM
Karyopharm Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2019
3:54 PM
Karyopharm Therapeutics (Filer)
Form POS AM
02/28/2019
3:29 PM
Karyopharm Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
3:17 PM
Karyopharm Therapeutics (Filer)
Form POSASR
02/28/2019
6:22 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
7:12 PM
Chione Ltd (Reporting)
Czernik Marcin (Reporting)
Hadjimichael Andreas (Reporting)
Hadjimichael George (Reporting)
Karyopharm Therapeutics (Issuer)
Smolokowski Wiaczeslaw (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
3:37 PM
Karyopharm Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
02/25/2019
4:14 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2019
4:09 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/25/2019
4:01 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
3:32 PM
Karyopharm Therapeutics (Issuer)
Peters Cameron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
3:29 PM
Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
3:27 PM
Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
3:25 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
3:23 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
3:16 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:41 PM
Karyopharm Therapeutics (Subject)
Ridgeback Capital Investments L.P. (Filed by)
Form SC 13G/A
02/14/2019
1:54 PM
Karyopharm Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/14/2019
6:44 AM
Consonance Capital Management LP (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G
02/13/2019
12:42 PM
Chione Ltd (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/12/2019
8:45 AM
Karyopharm Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/11/2019
3:06 PM
Karyopharm Therapeutics (Subject)
Kauffman Michael (Filed by)
Form SC 13G/A
01/28/2019
11:51 AM
FRANKLIN RESOURCES INC (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
01/24/2019
3:23 PM
Karyopharm Therapeutics (Issuer)
Peters Cameron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/18/2019
3:06 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2019
3:41 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
3:37 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
7:26 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
3:29 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2018
3:28 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
3:20 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
3:17 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
3:05 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2018
7:03 AM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2018
7:00 AM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
3:17 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
3:16 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
4:12 PM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
6:08 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2018
6:10 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
3:09 PM
Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2018
3:06 PM
Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2018
3:18 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel